Chronic hypnotic use: deadly risks, doubtful benefit

被引:95
|
作者
Kripke, DF [1 ]
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
hypnotics; epidemiology; mortality; hazard; triazolam; zolpidem; flurazepam;
D O I
10.1053/smrv.1999.0076
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the United States, roughly 2/3 of all hypnotic prescriptions go to chronic users, who have taken hypnotics for an average of 5 years or move. Two large prospective epidemiological studies have shown that reported hypnotic rise, especially use 30 times per month, is associated with an excess hazard of death. Indeed, use of hypnotics 30 times per month is associated with a similar mortality hazard to smoking 1-2 packs of cigarettes per day. Moreover, the hypnotic user's wish to improve daytime function is usually unfulfilled. The preponderance of evidence is that hypnotics impair performance, cognition and memory, increase the risk of automobile accidents and fails and promote unfavourable changes in personality. Due to tolerance, the sleep-promoting effects of hypnotics appear to be lost with chronic use. With long-term use, there is little controlled evidence that hypnotics produce benefits of any sort. More study of long-term hypnotic effects by public agencies is needed, but available evidence weighs strongly against long-term prescribing (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:5 / 20
页数:16
相关论文
共 50 条
  • [21] Decision irrationalities involving deadly risks
    Viscusi, W. Kip
    DeAngelis, Scott
    JOURNAL OF RISK AND UNCERTAINTY, 2018, 57 (03) : 225 - 252
  • [22] Doubtful health benefit of screening from 40 years of age
    Autier, Philippe
    NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (10) : 571 - 572
  • [23] SELF-REPORTED SLEEP DURING DISCONTINUATION OF CHRONIC HYPNOTIC USE
    Verkler, J.
    Koshorek, G.
    Roth, T.
    Roehrs, T.
    SLEEP, 2020, 43 : A190 - A190
  • [24] SELF-REPORTED SLEEP DURING DISCONTINUATION OF CHRONIC HYPNOTIC USE
    Withrow, D.
    Koshorek, G.
    Roth, T.
    Roehrs, T.
    SLEEP, 2018, 41 : A158 - A158
  • [25] Long-term use of hypnotic agents in the treatment of chronic insomnia
    Kramer, M
    PSYCHIATRIC SERVICES, 2005, 56 (06) : 752 - 752
  • [26] USE OF BLINDED HYPNOTIC TAPERING FOR HYPNOTIC DISCONTINUATION
    Edinger, J.
    Wamboldt, F.
    Holm, K.
    Johnson, R.
    Simmons, B.
    Tsai, S.
    Morin, C.
    SLEEP MEDICINE, 2019, 64 : S101 - S102
  • [27] Brain Death-diagnosis Precise Rules, doubtful Risks
    Erbe, Barbara
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2016, 233 (06) : 686 - 689
  • [28] USE OF BLINDED HYPNOTIC TAPERING FOR HYPNOTIC DISCONTINUATION
    Edinger, J. D.
    Walmboldt, F.
    Holm, K.
    Johnson, R. L.
    Simmons, B.
    Tsai, S.
    Morin, C.
    SLEEP, 2020, 43 : A195 - A195
  • [29] Doubtful health benefit of screening from 40 years of age
    Philippe Autier
    Nature Reviews Clinical Oncology, 2015, 12 : 570 - 572
  • [30] Effects of rimonabant on progression of atherosclerosis: Increased risks and doubtful benefits
    Jean-Louis G.
    Zizi F.
    McFarlane S.I.
    Current Cardiovascular Risk Reports, 2009, 3 (2) : 79 - 80